Gene-activated beta-interferon (Shire Human Genetic Therapies)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameGene-activated beta-interferon (Shire Human Genetic Therapies)
Drug Alias NameGene-activated β-IfnGA-INFβGene-activated interferon beta research programme - Shire Pharmaceuticals
ClassificationBiologics > Protein drugs > Recombinant polypeptideCell and gene therapy > Gene therapy
Mechanisms of ActionInterferon beta stimulants
TargetsInterferon beta
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesShire
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShire Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A